_____________ (insert effective date of agreement); Date” “Effective Needle Exchange” the Manager, Needle Exchange, Toronto “Manager, Public Health or his or her designate; Officer of Health” the Medical Officer of Health for the City of “Medical Toronto Health Unit or his or her designate; Kit” means an opioid overdose reversal kit provided to the Agency by “Naloxone the City that includes Naloxone nasal spray ("Naloxone"); is a web based harm reduction database managed by the City that “NEO” captures harm reduction service data and statistics such as the number of Naloxone Kits distributed to Clients, substances used by clients, referrals made and services provided. Client data must not include any PHI; Health Information” or shall have the meaning set out in PHIPA; “Personal “” means the and the “PHIPA” Personal Health Information Protection Act, 2004 regulations made thereunder, all as amended from time to time; means (insert Agency’s Address); and “Premises” the services provided by the Agency pursuant to section 2 of this “Services” Agreement. 2. SERVICES OF THE AGENCY The Agency agrees to furnish and perform the Services set out below: (1) develop policies and procedures for the distribution of Naloxone Kits, in consultation with the Medical Officer of Health, prior to distributing any Naloxone Kits to Clients; (2) comply with written instructions provided to the Agency by the City relating to proper use, administration, training and/or distribution of Naloxone Kits; (3) ensure that at least one Agency staff receives training by the City prior to distributing any Naloxone Kits to Clients. Using a train the trainer approach, ensure that Agency staff receive training prior to distributing Naloxone Kits to Clients; (4) distribute Naloxone Kits to Clients in accordance with all applicable provincial and federal laws;
“Effective Date” _____________ (insert effective date of agreement); “Manager, Needle Exchange” the Manager, Needle Exchange, Toronto Public Health or his or her designate; “Medical Officer of Health” the Medical Officer of Health for the City of Toronto Health Unit or his or her designate; “Naloxone Kit” means an opioid overdose reversal kit provided to the Agency by the City that includes Naloxone nasal spray ("Naloxone"); “NEO” is a web based harm reduction database managed by the City that captures harm reduction service data and statistics such as the number of Naloxone Kits distributed to Clients, substances used by clients, referrals made and services provided. Client data must not include any PHI; “Personal Health Information” or “” shall have the meaning set out in PHIPA; “PHIPA” means the Personal Health Information Protection Act, 2004 and the regulations made thereunder, all as amended from time to time; “Premises” means (insert Agency’s Address); and “Services” the services provided by the Agency pursuant to section 2 of this Agreement. 2. SERVICES OF THE AGENCY The Agency agrees to furnish and perform the Services set out below: (1) develop policies and procedures for the distribution of Naloxone Kits, in consultation with the Medical Officer of Health, prior to distributing any Naloxone Kits to Clients; (2) comply with written instructions provided to the Agency by the City relating to proper use, administration, training and/or distribution of Naloxone Kits; (3) ensure that at least one Agency staff receives training by the City prior to distributing any Naloxone Kits to Clients. Using a train the trainer approach, ensure that Agency staff receive training prior to distributing Naloxone Kits to Clients; (4) distribute Naloxone Kits to Clients in accordance with all applicable provincial and federal laws;
MOU-Toronto%20PHU.docx